Stock A185490 EYEGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart EyeGene Inc.

Equities

A185490

KR7185490000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
2,865 KRW -0.35% Intraday chart for EyeGene Inc. -1.38% -32.83%
2023 EyeGene Inc. announced that it has received KRW 15.000001688 billion in funding from BMI Korea Co., Ltd. CI
2023 EyeGene Inc. announced that it expects to receive KRW 15.000001688 billion in funding from BMI Korea Co., Ltd. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
EYEGENE INC. Stock EyeGene Inc.
 56.3M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 795B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 627B
JOHNSON & JOHNSON Stock Johnson & Johnson
 350B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 328B
ABBVIE INC. Stock AbbVie Inc.
 294B
  1. Stock Market
  2. Equities
  3. A185490 Stock
  4. Charts EyeGene Inc.
  5. Sector Chart